Skip to main content
Caplight Logo









OrganoTherapeutics SARL

OrganoTherapeutics SARL

Private
Esch-sur-AlzetteHealthcare & Life Scienceshttps://www.organo-therapeutics.com/

Last Round

VC Round

Jul 1, 2023

Total Funding Raised

$789,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OrganoTherapeutics SARL is a biotechnology company that develops human patient-specific midbrain organoids for the discovery and development of drug candidates targeting Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

midbrain organoidsParkinson's disease researchdrug discoverydisease modelingorgan-on-a-chippreclinical development3D cell culturephenotype-based screeningin vitro modelsneurodegenerative diseaseAI-based phenotypingassembloidspatient stratificationbiotech servicesPD-KG

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrganoTherapeutics SARL Comparables

Compare OrganoTherapeutics SARL with similar companies based on industry and business-model similarity.

OrganoTherapeutics SARL comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivodyne
84%
Herophilus
82%
Brain Organoid Therapeutics
82%

OrganoTherapeutics SARL Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 1, 2023
GrantMar 1, 2023
AcceleratorOct 15, 2020

OrganoTherapeutics SARL Investors

Notable investors and investment history

OrganoTherapeutics SARL investors
InvestorRounds
European Innovation Council FundGrant
Fit 4 StartAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 2190% MoM, reaching 1.3K.

  • Jul 1, 2023

    Completed a VC Round funding round.

OrganoTherapeutics SARL Filings

Explore SEC and related filing metadata, where available.

OrganoTherapeutics SARL filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OrganoTherapeutics SARL's valuation, stock price, and market status.

Is OrganoTherapeutics SARL a public or private company?

OrganoTherapeutics SARL is a private company.

What is the current stock price of OrganoTherapeutics SARL?

OrganoTherapeutics SARL is a private company with no public stock price. No recent secondary market data is available.

How much is OrganoTherapeutics SARL worth (valuation)?

Valuation information for OrganoTherapeutics SARL is not publicly available.

Can I buy OrganoTherapeutics SARL stock?

OrganoTherapeutics SARL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OrganoTherapeutics SARL's last funding round?

OrganoTherapeutics SARL's most recent funding round was VC Round on July 1, 2023.

Who are the main investors in OrganoTherapeutics SARL?

Key investors in OrganoTherapeutics SARL include European Innovation Council, Fit 4 Start.

Will OrganoTherapeutics SARL IPO soon?

No public IPO plans have been announced for OrganoTherapeutics SARL.

How can I track OrganoTherapeutics SARL secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OrganoTherapeutics SARL's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEsch-sur-Alzette
Employee Range9
Year Founded2019
Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?